Characterisation of hepcidin response to holotransferrin treatment in CHO TRVb-1 cells
Mehta, K, Greenwell, P, Renshaw, D, Busbridge, M, Garcia, M, Farnaud, S and Patel, VB (2015). Characterisation of hepcidin response to holotransferrin treatment in CHO TRVb-1 cells. Blood Cells, Molecules, and Diseases. 55 (2), pp. 110-118.
|Authors||Mehta, K, Greenwell, P, Renshaw, D, Busbridge, M, Garcia, M, Farnaud, S and Patel, VB|
Iron overload coupled with low hepcidin levels are characteristics of hereditary haemochromatosis. To understand the role of transferrin receptor (TFR) and intracellular iron in hepcidin secretion, Chinese hamster ovary transferrin receptor variant (CHO TRVb-1) cells were used that express iron-response-element-depleted human TFRC mRNA (TFRC∆IRE). Results showed that CHO TRVb-1 cells expressed higher basal levels of cell-surface TFR1 than HepG2 cells (2.2-fold; p < 0.01) and following 5 g/L holotransferrin treatment maintained constitutive over-expression at 24h and 48 h, contrasting the HepG2 cells where the receptor levels significantly declined. Despite this, the intracellular iron content was neither higher than HepG2 cells nor increased over time under basal or holotransferrin-treated conditions. Interestingly, hepcidin secretion in CHO TRVb-1 cells exceeded basal levels at all time-points (p < 0.02) and matched levels in HepG2 cells following treatment. While TFRC mRNA expression showed expected elevation (2h, p < 0.03; 4h; p < 0.05), slc40a1 mRNA expression was also elevated (2 h, p < 0.05; 4 h, p < 0.03), unlike the HepG2 cells. In conclusion, the CHO TRVb-1 cells prevented cellular iron-overload by elevating slc40a1 expression, thereby highlighting its significance in the absence of iron-regulated TFRC mRNA. Furthermore, hepcidin response to holotransferrin treatment was similar to HepG2 cells and resembled the human physiological response.
|Keywords||1103 Clinical Sciences; Immunology|
|Journal||Blood Cells, Molecules, and Diseases|
|Journal citation||55 (2), pp. 110-118|
|Digital Object Identifier (DOI)||doi:10.1016/j.bcmd.2015.05.002|
|08 May 2015|
|Publication process dates|
|Deposited||02 Oct 2018|
|Accepted||06 May 2015|
|Accepted author manuscript|
CC BY-NC-ND 4.0
0views this month
4downloads this month